NovoCure Ltd (NVCR)
30.83
+0.43
(+1.41%)
USD |
NASDAQ |
Dec 20, 16:00
30.81
-0.02
(-0.06%)
After-Hours: 20:00
NovoCure Profit Margin (Quarterly): -19.71% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Abbott Laboratories | 15.48% |
| LeMaitre Vascular Inc | 20.32% |
| Insulet Corp | 14.25% |
| Globus Medical Inc | 8.28% |
| Perspective Therapeutics Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -40.74% |
| Return on Assets | -12.81% |
| Return on Invested Capital | -15.43% |
| Gross Profit Margin (Quarterly) | 77.19% |
| Operating Margin (Quarterly) | -20.69% |
| Return on Net Operating Assets | -61.28% |